CERo Therapeutics Holdings Inc.
CERO
Get informed when a big investor buys or sells
+ FollowMarket Cap$451.12K
Close$
$1.45
12846.4% upside
Current Fair Value
12846.4% upsideUndervalued by 12846.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $451,124.00 |
|---|---|
| Enterprise Value | $8.14 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-22.58 |
| Beta | 0.16 |
| Outstanding Shares | 42,175,020 |
Return
| Return on Equity | 416.30% |
|---|---|
| Return on Assets | -6684.03% |
| Return on Invested Capital | 54.48% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.01 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.49 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.06 |
| Debt to Equity | -0.28 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
$-0.80
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
September 2, 2026
EPS Estimate
$-0.80
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.55%▼ 0.31% |
|---|---|
| Total Invested | $798,684▼ 66.39% |
| Investors Holding | 10▲ 2.00% |
ESG Score
No data